Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-dexrazoxane | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [Dexrazoxane co-treated with Doxorubicin] results in decreased expression of FSTL3 protein | CTD | PMID:30517846 | 1,2-dimethylhydrazine | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of FSTL3 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of FSTL3 mRNA | CTD | PMID:30723492 | 17beta-estradiol | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of FSTL3 mRNA | CTD | PMID:23019147 | 17beta-estradiol | multiple interactions | ISO | FSTL3 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of FSTL3 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FSTL3 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FSTL3 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fstl3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FSTL3 mRNA | CTD | PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FSTL3 mRNA | CTD | PMID:20106945 and PMID:21632981 | 4,4'-sulfonyldiphenol | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | bisphenol S results in increased expression of FSTL3 mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Fenretinide results in increased expression of FSTL3 mRNA | CTD | PMID:28973697 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of FSTL3 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of FSTL3 mRNA | CTD | PMID:22504374 | acrylamide | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of FSTL3 mRNA | CTD | PMID:32763439 | all-trans-retinoic acid | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Tretinoin results in increased expression of FSTL3 mRNA | CTD | PMID:36189433 | all-trans-retinoic acid | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FSTL3 mRNA | CTD | PMID:36189433 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FSTL3 mRNA | CTD | PMID:16483693 | arsenite(3-) | multiple interactions | ISO | FSTL3 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to FSTL3 protein] | CTD | PMID:32406909 | atrazine | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Atrazine results in increased expression of FSTL3 mRNA | CTD | PMID:18461179 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of FSTL3 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to FSTL3 promoter] | CTD | PMID:19654925 | benzo[a]pyrene | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of FSTL3 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | FSTL3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of FSTL3 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FSTL3 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FSTL3 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | Fstl3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FSTL3 mRNA | CTD | PMID:30245210 | bisphenol A | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of FSTL3 mRNA | CTD | PMID:30951980 and PMID:32370801 | bisphenol A | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FSTL3 mRNA | CTD | PMID:29275510 | bisphenol F | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | bisphenol F results in increased expression of FSTL3 mRNA | CTD | PMID:30951980 | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of FSTL3 mRNA | CTD | PMID:32479839 | butan-1-ol | multiple interactions | ISO | FSTL3 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FSTL3 mRNA | CTD | PMID:29432896 | butanal | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of FSTL3 mRNA | CTD | PMID:26079696 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of FSTL3 mRNA | CTD | PMID:19167457 | cadmium atom | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Cadmium results in increased expression of FSTL3 mRNA | CTD | PMID:24376830 | cadmium atom | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FSTL3 mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FSTL3 mRNA | CTD | PMID:37325564 | carbon nanotube | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloropicrin | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of FSTL3 mRNA | CTD | PMID:26352163 | chlorpyrifos | decreases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of FSTL3 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of FSTL3 mRNA | CTD | PMID:33545341 | cisplatin | multiple interactions | ISO | FSTL3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of FSTL3 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of FSTL3 mRNA | CTD | PMID:19320972 | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of FSTL3 mRNA | CTD | PMID:26033743 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of FSTL3 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of FSTL3 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of FSTL3 mRNA | CTD | PMID:26033743 | copper(II) sulfate | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of FSTL3 mRNA | CTD | PMID:16283523 and PMID:19549813 | corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of FSTL3 mRNA | CTD | PMID:15755911 | cyclosporin A | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of FSTL3 mRNA | CTD | PMID:20106945 and PMID:25562108 | cyclosporin A | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of FSTL3 mRNA | CTD | PMID:27989131 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of FSTL3 mRNA | CTD | PMID:23914054 | dextran sulfate | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FSTL3 mRNA | CTD | PMID:29950665 | diethyl maleate | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of FSTL3 mRNA | CTD | PMID:33545341 | dioxygen | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FSTL3 mRNA | CTD | PMID:30529165 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FSTL3 mRNA | CTD | PMID:33729688 | doxorubicin | decreases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of FSTL3 protein | CTD | PMID:30517846 | doxorubicin | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [Dexrazoxane co-treated with Doxorubicin] results in decreased expression of FSTL3 protein | CTD | PMID:30517846 | ethanol | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of FSTL3 mRNA | CTD | PMID:30517762 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of FSTL3 mRNA | CTD | PMID:33387578 | lipopolysaccharide | multiple interactions | ISO | FSTL3 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of FSTL3 mRNA | CTD | PMID:35811015 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of FSTL3 mRNA | CTD | PMID:28801915 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of FSTL3 mRNA | CTD | PMID:22504374 | mifepristone | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Mifepristone results in decreased expression of FSTL3 mRNA | CTD | PMID:17584828 | mifepristone | decreases expression | EXP | | 6480464 | Mifepristone results in decreased expression of FSTL3 mRNA | CTD | PMID:25972201 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FSTL3 mRNA | CTD | PMID:36189433 | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of FSTL3 mRNA | CTD | PMID:22110744 | nickel sulfate | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of FSTL3 mRNA | CTD | PMID:22714537 | niclosamide | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of FSTL3 mRNA | CTD | PMID:36318118 | paracetamol | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of FSTL3 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FSTL3 mRNA | CTD | PMID:33387578 | phenylephrine | affects expression | EXP | | 6480464 | Phenylephrine affects the expression of FSTL3 mRNA | CTD | PMID:18158353 | potassium chromate | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of FSTL3 mRNA | CTD | PMID:22714537 | propanal | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of FSTL3 mRNA | CTD | PMID:26079696 | quercetin | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Quercetin results in increased expression of FSTL3 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | FSTL3 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | silicon dioxide | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of FSTL3 mRNA | CTD | PMID:23806026 | silver atom | decreases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Silver results in decreased expression of FSTL3 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Silver results in decreased expression of FSTL3 mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FSTL3 mRNA | CTD | PMID:22714537 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of FSTL3 mRNA | CTD | PMID:19281266 | temozolomide | increases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of FSTL3 mRNA | CTD | PMID:31758290 | tetrachloromethane | affects expression | ISO | Fstl3 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of FSTL3 mRNA | CTD | PMID:17484886 | tetrachloromethane | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of FSTL3 mRNA | CTD | PMID:30517762 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of FSTL3 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of FSTL3 mRNA | CTD | PMID:27760801 | titanium dioxide | multiple interactions | ISO | Fstl3 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FSTL3 mRNA | CTD | PMID:29950665 | valproic acid | increases expression | ISO | Fstl3 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of FSTL3 mRNA | CTD | PMID:21427059 | valproic acid | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FSTL3 mRNA | CTD | PMID:25716160 and PMID:29154799 | valproic acid | increases methylation | ISO | FSTL3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of FSTL3 gene | CTD | PMID:29154799 | zoledronic acid | decreases expression | ISO | FSTL3 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of FSTL3 mRNA | CTD | PMID:24714768 | |